ReleaseWire Connect

GlobalData's mining industry offering, 'Asia-Pacific Uranium Mining Regulatory and Fiscal Regime Report, 2012 - Regulatory Framework, Rights and Obligations and Key Fiscal Terms' provides an understanding of the regulatory framework and fiscal regime of the Asia-Pacific uranium mining industry, comprising Kazakhstan, Australia, Uzbekistan, China and India. The report includes information about the governing authorities, governing laws and key fiscal terms pertaining to the uranium mining industry in the respective countries, with a brief overview of the relevant uranium mining industries. This report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "Cyberonics, Inc. Market Share Analysis" provides in-depth information on Cyberonics, Inc.'s market position in the different medical equipment markets it operates in. The report provides Cyberonics, Inc. market share information in one key market category - Neurostimulation Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

Core Views: Following 2011's political crisis, our forecasts see trend growth in Egypt settling at a lower rate over the coming five years as the political transition from authoritarian rule to competitive democracy raises political risks, slows reform momentum and weakens investment inflows. We forecast real GDP to expand by an average 5.2% between 2012 and 2016. The current transitional government is likely to sign an IMF Stand-By Arrangement before the end of the parliamentary election cycle. Such an agreement would not only provide a low-cost source of external financing, but also act as a key policy anchor. Although parliamentary elections tentatively scheduled for late 2011 are likely to be the most free and fair in Egypt's history, we expect the military to maintain considerable behind-the-scenes influence in policymaking. We do not expect the armed forces to relinquish a large share of their economic interests. The Muslim Brotherhood is likely to garner the largest share of votes in the upcoming election. Its ability to unilaterally pursue its own policies will, however, be tempered by the need to form a coalition government with parties of different ideologies. Major Forecast Changes We have revised down our forecast for the Egyptian pound in 2012, and now project the unit trading at an average EGP6.1000/US $ On the back of weaker-than-expected tourism receipts and a likely decline in remittance inflows, we expect the current account shortfall to fall further into the red over the coming months, and project the deficit coming in at 1.9% of GDP in FY 2011/12. Key Risks To Outlook Although the central bank retains a large stock of foreign reserves, a more prolonged period of capital outflows than currently envisaged would add considerable pressure to balance of payments stability. Maintaining confidence in the exchange rate will be the central goal of the central bank over the coming months. A resumption of large-scale protests on the same scale as witnessed in late January would do further harm to the country's all-important tourism sector and hold back the economy's growth potential.

Biocides are substances that kill or inhibit all life forms when introduced in sufficient concentration and/or duration. They are used to control harmful organisms and control bacterial and fungal growth. Different types of biocide such as halogen compounds, metallic compounds, organosulfurs, organic acids, phenolic, etc. are used for various applications in personal care, water treatment, wood preservation, food and beverage, paints and coatings, and others. Growth in water treatment market on account of increasing water consumption due to population growth, changing food habits, and climate change is a major driver for global biocide market.

Head-Up Display (HUD) Market - Global Forecasts & Analysis (2012 - 2017), By Technologies, Components (Projector, Video Generator, Combiner, Panel [LCD, OLED] & Others) & Applications (Aviation [ Military/defense & Civil], Auto & Others)

GlobalData's new report, "Asia-Pacific Surgical Equipment Market Outlook to 2018 -Electrosurgical Devices, Hand Instruments and Surgical Sutures" provides key market data on the Asia-Pacific Surgical Equipment market - Australia, China, India and Japan. The report provides value (USD million) data for all the market categories - Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

GlobalData, the industry analysis specialist, has released its new report, "Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Narcolepsy Therapeutics market. The report identifies the key trends shaping and driving the global Narcolepsy Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Narcolepsy Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

"Business Restructuring in International Oil Companies (IOCs) - Increasing Focus on Upstream Business With Spin-Offs and Divestitures in Downstream Operations", is the latest report from GlobalData analyzing the recent divestments and spin-offs by integrated oil companies in the oil and gas industry. The report provides information about the key divestments in the downstream sector undertaken by integrated companies in order to raise the capital needed to focus on upstream activities. The report gives details about the spinoff of Marathon Oil Corporation, which formed an upstream pure play company with the same name and Marathon Petroleum Corporation, a downstream pure play company. It also provides information regarding the planned spinoff of ConocoPhillips to form a separate downstream company, Phillips 66 in May 2012. Information about divestments of downstream assets and plans for growth in the upstream sector by major integrated oil companies also features in the report, which is built using data and information sourced from company reports, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Cabot Oil & Gas Corporation (Cabot) is an oil and gas company, mainly engaged in the exploration, development and production activities in the US. The company's major Exploration and Production (E&P) activities in the US are focused in the northern and southern regions of the country. Its operations in the northern region are mainly spread across the areas of Appalachia and the Rocky Mountains. Cabot's operations in the southern region include its E&P activities in Texas and Oklahoma.

GlobalData's clinical trial report, "Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2012" provides data on the Exocrine Pancreatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Exocrine Pancreatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Exocrine Pancreatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.